glp-1 and kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective GLP-1 drugs may extend life,

BPC-157 is notably stable in gastric acid, unusual for a peptide

Market and Financial Impact: The anti-obesity medicines market is projected to grow to $30 billion by 2030 across the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan)

BPC-157 upregulates growth hormone receptors on fibroblasts while TB-500 enhances the activity of those receptors

Early pregnancy losses and increased incidences of minor visceral (kidney, liver) and skeletal (sternebra) fetal abnormalities were observed at 0.0025 mg/kg/day, at clinically relevant exposures

With FDA-approved products widely available again, compounding is no longer permitted for general access